Back to Search
Start Over
[New manifestation of a type 2-inflammation in the upper respiratory tract with nasal polyposis under treatment with an asthma biologic].
- Source :
-
Praxis [Praxis (Bern 1994)] 2024 May; Vol. 113 (5), pp. 138-141. - Publication Year :
- 2024
-
Abstract
- Introduction: For 7 years we gained experience of how asthma and chronic rhinosinusitis with nasal polyposis respond to biologics. In contrast, it is much less known, how ASA/NSAID intolerance (Widal's disease) behaves under biologicals. We therefore describe the case of a patient with both clinical conditions who reacted with a severe intolerance reaction under perioperative metamizole administration.<br />Competing Interests: Es bestehen keine Interessenkonflikte<br /> (© 2024 Aerzteverlag medinfo AG.)
- Subjects :
- Female
Humans
Male
Middle Aged
Anti-Asthmatic Agents adverse effects
Anti-Asthmatic Agents therapeutic use
Antibodies, Monoclonal, Humanized adverse effects
Antibodies, Monoclonal, Humanized therapeutic use
Diagnosis, Differential
Dipyrone adverse effects
Dipyrone therapeutic use
Asthma, Aspirin-Induced drug therapy
Asthma, Aspirin-Induced diagnosis
Nasal Polyps drug therapy
Rhinosinusitis drug therapy
Subjects
Details
- Language :
- German
- ISSN :
- 1661-8157
- Volume :
- 113
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Praxis
- Publication Type :
- Academic Journal
- Accession number :
- 38864100
- Full Text :
- https://doi.org/10.23785/PRAXIS.2024.05.005